Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/08/22 07:01:00 on US and Canada Markets.
Company Cancels Earnings Call in Light of Transaction with Vista Equity Partners S econd Quarter Total Revenu e of $208.6 Million T otal Revenue Growth of 23% From Second Quarter 2021 Avalara, Inc. (NYSE: AVLR), a leading provider of tax compl...
MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) today announced revisions to its SailSAFE health and safety protocols which further align the Company to the broader travel, leisure and hospitality industry worldwide. Va...
NUBURU, Inc. (“NUBURU”) has entered into a business combination agreement with Tailwind Acquisition Corp. (“TWND”); Upon closing, the combined company expects to be traded under the ticker symbol “BURU.” NUBURU is a leading innovator in hi...
VANCOUVER, BC / ACCESSWIRE / August 8, 2022 / Fury Gold Mines Limited (TSX:FURY), (NYSE American:FURY) ("Fury" or the "Company") is pleased to announce that Fury and Newmont Corporation ("Newmont") as purchasers have concurrently agreed, through their respective subsidiaries, to buy-out th...
Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the second quarter ended June 30, 2022. Q2 2022 Highlights Revenue grew 26% year-over-year to $473 million US revenue grew 45% year-over-year to $290 million Commercial revenue grew 46% ye...
Quarterly Revenue of $34.6 Million, Marking Third Consecutive Quarter of Year-Over-Year Revenue Growth High Margin, Recurring and Services Revenue up 9% Year-Over-Year to $19.8 Million, Reflecting Company’s Focus on Driving SaaS and Software Revenue Ration...
Announced results from two of the ongoing Phase 2 clinical trials of PDS0101 in multiple, difficult-to-treat HPV16-related cancers presented at the American Society of Clinical Oncology meeting Promising pre-clinical data on universal flu vaccine program presented at American So...
- Launched Exclusive In Vivo Gene Insertion Collaboration with Novartis to Develop Single ARCUS Nuclease as Potential One-time Hemoglobinopathy Treatment - Extended Cash Runway to End of 2024 - Reported Updates Across Allogeneic CAR T Pipeline; Interim Results from Lea...
Avalara shareholders to receive $93.50 per share in cash Avalara to become a private company upon completion of the transaction Avalara, Inc. (NYSE: AVLR), a leading provider of tax compliance automation for businesses of all sizes, today announced it has entered int...
CALGARY, Alberta, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident", "PPR" or the "Company") today announces our financial and operating results for the three and six months ended June 30, 2022. PPR’s unaudited condensed interim consolidated...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
15.43%Change Percent:
Five Below Inc. Company Name:
FIVE Stock Symbol:
NASDAQ Market:
fivebelow.com Website: